Last updated 2026-06-18
- Acquired by Medivie Therapeutic, Apr 2014
- Raised funding round
Total raised
—
Last:
Stage
Acquired
Founded
1999
Headcount
31
HQ
Modi'in-Maccabim-Re'ut, Israel
Sector
Health Tech & Life Sciences
About
Glycominds International, an innovative diagnostics company, develops and commercializes gastrointestinal disease management tools and services. Glycominds' GI dry serum testing allow physicians to help identify patients who have Celiac Disease and Inflammatory Bowel Diseases (mainly Crohns Disease and Ulcerative Colitis) to achieve early, non-invasive, accurate and cost-effective diagnosis, predict Crohns Disease patients at a higher risk for more complicated disease, as well as monitoring Anti-TNF therapy. Glycominds was acquired by Medivie Therapeutic in 2014, expanding its product line.
Funding history · 1 round · — total
Date unknown
Undisclosed
Q&A
- What is Glycominds' primary business?
- Glycominds is a molecular diagnostics company that develops and commercializes gastrointestinal disease management tools and services, focusing on Celiac Disease and Inflammatory Bowel Diseases.
- When was Glycominds founded?
- Glycominds was founded in January 1999.
- What is the current status of Glycominds?
- Glycominds was acquired by Medivie Therapeutic in April 2014 and is currently inactive.
- Who acquired Glycominds and when?
- Glycominds was acquired by Medivie Therapeutic in April 2014.
- Where was Glycominds headquartered?
- Glycominds was headquartered in Modi'in-Maccabim-Re'ut, Israel.
- Who are the co-founders of Glycominds?
- The co-founders of Glycominds are Nir Dotan and Avi (Avinoam) Dukler, Ph.D.
- What types of diseases did Glycominds' diagnostic tools target?
- Glycominds' diagnostic tools targeted Celiac Disease and Inflammatory Bowel Diseases, including Crohn's Disease and Ulcerative Colitis.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesMedical Devices IndustryMedical Equipment
Business model
B2B
Tags
chronic-deseasescrohn-s-diseasepharmaceuticalsceliac-diseaseautoimmune-diseases
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1999-1 |
|---|---|
| Employees (exact) | 31 |
| Offices | Simi Valley |
| Status reason | Acquired (Inactive) by Medivie Therapeutic on Apr 2014 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Medivie Therapeutic 2014-04
Radar intelligence
Patents
| EPO | 17 |
|---|
Publications (Crossref)
| Works | 6 |
|---|